Sort   by:  
 Page size 
UnknownPhase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.
Not available
S-EPMC5321073 | biostudies-literature
UnknownSorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinoma.
Not available
S-EPMC9158473 | biostudies-literature
TranscriptomicsGenetics of gene expression across innate immune stimulation in primary monocytes
Gene expression arrays and genotyping data in primary human monocytes from healthy individuals of European ancestry that have either been unstimulated (naive) or exposed to IFN gamma (24h) or Lipopolysaccharide (2 or 24h duration).
ORGANISM(S): Homo sapiens 
2014-03-26 | E-MTAB-2232 | biostudies-arrayexpress
UnknownStudy in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
Not available
S-EPMC9535216 | biostudies-literature
UnknownFatigue in levodopa-naive subjects with Parkinson disease.
Not available
S-EPMC2937041 | biostudies-literature
UnknownExcessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
Not available
S-EPMC5841393 | biostudies-literature
UnknownMeta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
Not available
S-EPMC3354734 | biostudies-literature
UnknownGrowth differences between North American and European children at risk for type 1 diabetes.
Not available
S-EPMC3335929 | biostudies-literature
UnknownHydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
Not available
S-EPMC4225544 | biostudies-literature
UnknownLarge-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Not available
S-EPMC4146673 | biostudies-literature
Sort   by:  
 Page size